Image

North America Diagnostic Tests Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • Aug 2020
  • North America
  • 350 Pages
  • No of Tables: 158
  • No of Figures: 66

North America Diagnostic Tests Market, By Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solution (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription Based Testing, OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument & Point of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat, and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology, and Others), Testing Type (Biochemistry, Hematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult & Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Others), Distribution Channel (Direct Tenders, Retail Sales, Online Sales), Country  (U.S., Canada, Mexico) Industry Trends & Forecast to 2027    

North America Diagnostic Tests Market Market Analysis and Insights: North America Diagnostic Tests Market

Diagnostic tests market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 9.0% in the forecast period of 2020 to 2027 and is expected to reach USD 286,081.12 million by 2027 from USD 119,659.21 million in 2019. Increase in prevalence of chronic diseases, rising number of IVD test across the globe, adequate reimbursement policies, improving diagnosis seeking rate across the globe & extending reach of molecular diagnostics are the major drivers which propelled the demand of the market in the forecast period.

Across the globe there are more than 110 diagnostic tests are currently used in the processes. They are either used for monitoring the progression rate of the disease or used in the detection of the diseases. Other than that diagnostic equipment and tools are also used in helping the evaluation and treatment of the effectiveness of the treatment procedure. Technically tests are non-invasive and invasive. Diagnostic tests can be of various types such as MRI, X-rays, ultrasound, and mammography among others. 

The diagnostic tests are reflected as advancement for the diagnosis, evaluation of the rate of disease, translational research among others.  Due to the recent advancements in the research and development related to cancer and also due to the increase in the interest for new drug development, anti-cancer drugs the use of diagnostic tests have been increased.

Diagnostic tests are considered as an effective tool in the field of biomedical research, for the early detection of the disease. They also help in differentiating between the adult and childhood cancer. The adoption of the new therapies, patient specific therapies, and personalized medicine are all established by the use of diagnostic tests in the basic cancer research and drug development for increase the rate of early detection and diagnosis of the disease that are preventable at early stage among the chronic and non-chronic disease as well.   

This diagnostic tests market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Diagnostic Tests Market North America Diagnostic Tests Market Scope and Market Size

Diagnostic tests market is segmented on the basis of type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the diagnostic tests market is classified into glucose test, infectious diseases test, cytology test, CBC test, blood culture test, syphilis test, urea test, C-reactive protein test, antigen test, HBA1C test, pregnancy test, lipid profile test, electrolytes test, liver function test, stool helicobacter pylori test, calcium test, crossmatch test, thyroid function test, stool microscopy test, urine microscopy test, unit packed RBCs test, ESR test and others test. In 2020, glucose test segment is expected to dominate the market due to continuous increase in number diabetic patients in the world. For instance: according to International Diabetes Federation “approximately 463 million people from age group of 20-79 years are living with diabetes and the by 2045 expected to rise to 700 million.
  • On the basis of solution, the diagnostic tests market is segmented into services and products. In 2020, services segment is expected to dominate the market due to continuous increasing number of diagnosis tests around world.  For instance laboratory testing is the single highest-volume medical activity with an estimated 13,000 million performed each year tests in the U.S. and the average citizen in the UK, has 14 tests per year performed by a laboratory medicine specialist.
  • On the basis of technology, the diagnostic tests market is segmented into immunoassay-based, PCR-based, next gene sequencing, spectroscopy-based, chromatography-based, microfluidics, substrate technology and others. In 2020, immunoassay-based segment is expected to dominate the market due to increasing adoption of immunoassay-based diagnosis tests. Clinicians are increasingly using immunoassay-based diagnosis tests more than any other technology, because of immunoassay technology based diagnosis tests offer sensitive, are relatively easy to use with specific results. In addition, some Immunoassay technology based diagnosis tests methods helps to yield improved precision, are rapid, and are relatively easy to automate, thus requiring less hands-on involvement.,  
  • On the basis of mode of testing, the diagnostic tests market is segmented into prescription-based testing and OTC testing. In 2020, prescription-based testing segment is expected to dominate the market as majority of the diagnosis test are prescription-based testing in the order to help in detection, treatment and control disease
  • On the basis of approach, the diagnostic tests market is segmented into molecular diagnostic instrument, in-vitro diagnostic instrument and point of care testing instrument. In 2020, in-vitro diagnostic instrument segment is expected to dominate the market as in-vitro diagnostic preference is continuously increasing to analyse samples such as blood and saliva to detect diseases or other conditions. Further, in-vitro diagnostic instrument is expected to increase in the forecast period with continuous increase in geriatric population and the subsequent growth in the prevalence of infectious and chronic diseases.
  • On the basis of sample type, the diagnostic tests market is segmented into urine, saliva, blood, hair, sweat and others. In 2020, blood segment is expected to dominate the market as majority of the diagnosis test are prescription-based testing in the order to help in detection, treatment and control disease.
  • On the basis of application, the diagnostic tests market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, odontology and others. In 2020, cardiology segment is expected to dominate the market due to continuous increase in number of heart patients and other cardiovascular diseases around the world. Majority of the cardiovascular diseases require diagnosis test for the detection and treatment of cardiovascular diseases
  • On the basis of testing type, the diagnostic tests market is segmented into biochemistry, hematology, microbiology, histopathology and others. In 2020, hematology segment is expected to dominate the market as mostly diagnosis test are performed by using blood for detection and identification of diseases
  • On the basis of age, the diagnostic tests market is segmented into pediatric, adult and geriatric. In 2020, geriatric segment is expected to dominate the market as majority of diagnosis tests are performed on geriatric patients. Geriatric patients require regular monitoring/diagnosis as geriatric patients are more prone to infectious, chronic diseases and non-chronic diseases
  • On the basis of end user, the diagnostic tests market is segmented into hospitals, diagnostic center, research labs & institutes, research institute, homecare, blood banks, specialty clinics, ambulatory surgical centers and others. In 2020, hospitals segment is expected to dominate the market as as hospitals are performing various diagnostic tests such as glucose test, infectious diseases test, cytology test, CBC test, blood culture test, syphilis test, urea test, C-reactive protein test, antigen test, HBA1C test, causing for detection and treatment of serious disease or other major conditions. 
  • On the basis of distribution channel, the diagnostic tests market is segmented into direct tenders, retail sales and online sales. In 2020, direct tenders segment is expected to dominate the market as most of the industrial user, clinical laboratories, academic and research institutes, diagnostic centers prefer direct tenders for seeking the benefits of bulk buying, discounts and easy availability of products.   

Diagnostic Tests Market Country Level Analysis

The diagnostic tests market is analysed and market size information is provided by country, type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel.

The countries covered in the diagnostic tests market report are the U.S., Canada, and Mexico.  

  • In North America, the U.S. is dominating the market with increasing adoption of diagnostic tests for preclinical research of diagnostic tests in the market

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, and regulatory acts are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Government & Private Sector in Diagnostic Tests Market is Creating New Opportunities for Players in the Diagnostic Tests Market 

Diagnostic tests market also provides you with detailed market analysis for every country growth in aesthetic industry with diagnostic tests sales, impact of advancement in the diagnostic tests and changes in regulatory scenarios with their support for the diagnostic tests market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Diagnostic Tests Market Share Analysis

Diagnostic tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to diagnostic tests market. .

Some of the major players operating in this market are ABBOTT, Danaher, BD, Thermo Fisher Scientific Inc., ACON Laboratories Inc., Hemosure, Inc., MicroGen Diagnostics, QIAGEN, Grifols, S.A, BODITECH MED INC., Chembio Diagnostic Systems, Inc., Nanoentek, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., BIOMEDOMICS INC, EKF Diagnostics Holdings plc, Siemens Healthcare GmbH, and PerkinElmer Inc among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.  

For instance,

  • In March 2020, Siemens Healthcare GmbH officially announced the launch of RAPIDPoint 500e Blood Gas Analyzer, this expanded the product portfolio of the company and is also used in COVID-19 efforts. This is helping in generating more revenue from the line.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the diagnostic tests market which also provides the benefit for organisation to improve their offering for diagnostic tests.

Customization Available: North America Diagnostic Tests Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 NUMBER OF NEW CANCER CASES IN 2018, BOTH SEXES, ALL AGES IN THE U.S. 54

TABLE 2 INDICATIVE REIMBURSEMENT FOR IN VITRO DIAGNOSTIC TESTS IN THE U.S. 56

TABLE 3 REVENUE FROM DIFFERENT MOLECULAR DIAGNOSTIC TEST (2009-2015) 57

TABLE 4 LIST OF SUBSIDIARIES OF THERMO FISHER SCIENTIFIC INC. 60

TABLE 5 LIST OF SUBSIDIARIES OF DANAHER CORPORATION 61

TABLE 6 LIST OF SUBSIDIARIES OF ABBOTT 61

TABLE 7 DIFFERENT ASSOCIATIONS FOR DIAGNOSTICS 62

TABLE 8 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 70

TABLE 9 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 81

TABLE 10 NORTH AMERICA PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 82

TABLE 11 NORTH AMERICA PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (UNITS) 82

TABLE 12 NORTH AMERICA INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY DIAGNOSTIC TYPE, 2018-2027 (USD MILLION) 83

TABLE 13 NORTH AMERICA INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 84

TABLE 14 NORTH AMERICA REAGENTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 86

TABLE 15 NORTH AMERICA CONSUMABLES IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 87

TABLE 16 NORTH AMERICA CONSUMABLES IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 88

TABLE 17 NORTH AMERICA STAINS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 88

TABLE 18 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 93

TABLE 19 NORTH AMERICA IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 94

TABLE 20 NORTH AMERICA SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 95

TABLE 21 NORTH AMERICA CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 96

TABLE 22 NORTH AMERICA MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 97

TABLE 23 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY MODE OF TESTING, 2018-2027 (USD MILLION) 102

TABLE 24 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY APPROACH, 2018-2027 (USD MILLION) 107

TABLE 25 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY SAMPLE TYPE, 2018-2027 (USD MILLION) 112

TABLE 26 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 118

TABLE 27 NORTH AMERICA CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 119

TABLE 28 NORTH AMERICA ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 121

TABLE 29 NORTH AMERICA ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 122

TABLE 30 NORTH AMERICA GASTROENTEROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 123

TABLE 31 NORTH AMERICA GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 124

TABLE 32 NORTH AMERICA NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 125

TABLE 33 NORTH AMERICA ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 126

TABLE 34 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY TESTING TYPE, 2018-2027 (USD MILLION) 131

TABLE 35 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY AGE, 2018-2027 (USD MILLION) 137

TABLE 36 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY END USER, 2018-2027 (USD MILLION) 142

TABLE 37 NORTH AMERICA DIAGNOSTICS TESTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION) 149

TABLE 38 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 155

TABLE 39 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 155

TABLE 40 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 156

TABLE 41 NORTH AMERICA PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 156

TABLE 42 NORTH AMERICA PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (UNITS) 156

TABLE 43 NORTH AMERICA INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY DIAGNOSTIC TYPE, 2018-2027 (USD MILLION) 156

TABLE 44 NORTH AMERICA INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 157

TABLE 45 NORTH AMERICA REAGENTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 157

TABLE 46 NORTH AMERICA CONSUMABLES IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 158

TABLE 47 NORTH AMERICA MEDIA CULTURE IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 158

TABLE 48 NORTH AMERICA STAINS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 158

TABLE 49 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 159

TABLE 50 NORTH AMERICA IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 159

TABLE 51 NORTH AMERICA CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 159

TABLE 52 NORTH AMERICA SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 160

TABLE 53 NORTH AMERICA MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 160

TABLE 54 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING, 2018-2027 (USD MILLION) 160

TABLE 55 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY APPROACH, 2018-2027 (USD MILLION) 160

TABLE 56 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE, 2018-2027 (USD MILLION) 161

TABLE 57 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 161

TABLE 58 NORTH AMERICA CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 162

TABLE 59 NORTH AMERICA ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 162

TABLE 60 NORTH AMERICA NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 162

TABLE 61 NORTH AMERICA ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 163

TABLE 62 NORTH AMERICA GASTROENTEROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 163

TABLE 63 NORTH AMERICA GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 163

TABLE 64 NORTH AMERICA ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 164

TABLE 65 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY TESTING TYPE, 2018-2027 (USD MILLION) 164

TABLE 66 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY AGE, 2018-2027 (USD MILLION) 164

TABLE 67 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY END USER, 2018-2027 (USD MILLION) 165

TABLE 68 NORTH AMERICA DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION) 165

TABLE 69 U.S. DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 166

TABLE 70 U.S. DIAGNOSTIC TESTS MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 166

TABLE 71 U.S. PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 167

TABLE 72 U.S. PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (UNITS) 167

TABLE 73 U.S. INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY DIAGNOSTIC TYPE, 2018-2027 (USD MILLION) 167

TABLE 74 U.S. INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 168

TABLE 75 U.S. REAGENTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 168

TABLE 76 U.S. CONSUMABLES IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 169

TABLE 77 U.S. MEDIA CULTURE IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 169

TABLE 78 U.S. STAINS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 169

TABLE 79 U.S. DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 170

TABLE 80 U.S. IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 170

TABLE 81 U.S. CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 170

TABLE 82 U.S. SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 171

TABLE 83 U.S. MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 171

TABLE 84 U.S. DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING, 2018-2027 (USD MILLION) 171

TABLE 85 U.S. DIAGNOSTIC TESTS MARKET, BY APPROACH, 2018-2027 (USD MILLION) 171

TABLE 86 U.S. DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE, 2018-2027 (USD MILLION) 172

TABLE 87 U.S. DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 172

TABLE 88 U.S. CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 173

TABLE 89 U.S. ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 173

TABLE 90 U.S. NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 173

TABLE 91 U.S. ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 174

TABLE 92 U.S. GASTROENTEROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 174

TABLE 93 U.S. GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 174

TABLE 94 U.S. ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 175

TABLE 95 U.S. DIAGNOSTIC TESTS MARKET, BY TESTING TYPE, 2018-2027 (USD MILLION) 175

TABLE 96 U.S. DIAGNOSTIC TESTS MARKET, BY AGE, 2018-2027 (USD MILLION) 175

TABLE 97 U.S. DIAGNOSTIC TESTS MARKET, BY END USER, 2018-2027 (USD MILLION) 176

TABLE 98 U.S. DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION) 176

TABLE 99 CANADA DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 177

TABLE 100 CANADA DIAGNOSTIC TESTS MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 177

TABLE 101 CANADA PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 178

TABLE 102 CANADA PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (UNITS) 178

TABLE 103 CANADA INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY DIAGNOSTIC TYPE, 2018-2027 (USD MILLION) 178

TABLE 104 CANADA INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 179

TABLE 105 CANADA REAGENTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 179

TABLE 106 CANADA CONSUMABLES IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 180

TABLE 107 CANADA MEDIA CULTURE IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 180

TABLE 108 CANADA STAINS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 180

TABLE 109 CANADA DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 181

TABLE 110 CANADA IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 181

TABLE 111 CANADA CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 181

TABLE 112 CANADA SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 182

TABLE 113 CANADA MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 182

TABLE 114 CANADA DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING, 2018-2027 (USD MILLION) 182

TABLE 115 CANADA DIAGNOSTIC TESTS MARKET, BY APPROACH, 2018-2027 (USD MILLION) 182

TABLE 116 CANADA DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE, 2018-2027 (USD MILLION) 183

TABLE 117 CANADA DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 183

TABLE 118 CANADA CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 184

TABLE 119 CANADA ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 184

TABLE 120 CANADA NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 184

TABLE 121 CANADA ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 185

TABLE 122 CANADA GASTROENTEROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 185

TABLE 123 CANADA GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 185

TABLE 124 CANADA ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 186

TABLE 125 CANADA DIAGNOSTIC TESTS MARKET, BY TESTING TYPE, 2018-2027 (USD MILLION) 186

TABLE 126 CANADA DIAGNOSTIC TESTS MARKET, BY AGE, 2018-2027 (USD MILLION) 186

TABLE 127 CANADA DIAGNOSTIC TESTS MARKET, BY END USER, 2018-2027 (USD MILLION) 187

TABLE 128 CANADA DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION) 187

TABLE 129 MEXICO DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 188

TABLE 130 MEXICO DIAGNOSTIC TESTS MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 189

TABLE 131 MEXICO PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 189

TABLE 132 MEXICO PRODUCTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (UNITS) 189

TABLE 133 MEXICO INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY DIAGNOSTIC TYPE, 2018-2027 (USD MILLION) 189

TABLE 134 MEXICO INSTRUMENTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2018-2027 (USD MILLION) 190

TABLE 135 MEXICO REAGENTS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 190

TABLE 136 MEXICO CONSUMABLES IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 191

TABLE 137 MEXICO MEDIA CULTURE IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 191

TABLE 138 MEXICO STAINS IN DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2018-2027 (USD MILLION) 191

TABLE 139 MEXICO DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 192

TABLE 140 MEXICO IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 192

TABLE 141 MEXICO CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 192

TABLE 142 MEXICO SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 193

TABLE 143 MEXICO MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 193

TABLE 144 MEXICO DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING, 2018-2027 (USD MILLION) 193

TABLE 145 MEXICO DIAGNOSTIC TESTS MARKET, BY APPROACH, 2018-2027 (USD MILLION) 193

TABLE 146 MEXICO DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE, 2018-2027 (USD MILLION) 194

TABLE 147 MEXICO DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 194

TABLE 148 MEXICO CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 195

TABLE 149 MEXICO ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 195

TABLE 150 MEXICO NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 195

TABLE 151 MEXICO ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 196

TABLE 152 MEXICO GASTROENTEROLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 196

TABLE 153 MEXICO GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 196

TABLE 154 MEXICO ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 197

TABLE 155 MEXICO DIAGNOSTIC TESTS MARKET, BY TESTING TYPE, 2018-2027 (USD MILLION) 197

TABLE 156 MEXICO DIAGNOSTIC TESTS MARKET, BY AGE, 2018-2027 (USD MILLION) 197

TABLE 157 MEXICO DIAGNOSTIC TESTS MARKET, BY END USER, 2018-2027 (USD MILLION) 198

TABLE 158 MEXICO DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION) 198

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions